[Diagnosis and therapy of Raynaud's phenomenon (author's transl)].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000627:therapeutic use; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005385:Fingers / Q000098:blood supply; D006801:Humans; D008297:Male; D008875:Middle Aged; D010992:Plethysmography, Impedance; D011928:Raynaud Disease / Q000175:diagnosis* / Q000188:drug therapy; D015016:Yohimbine / Q000627:therapeutic use
D004338:Drug Combinations; D004088:Dihydroergotoxine; D015016:Yohimbine; D004087:Dihydroergotamine
Das Raynaud-Phänomen: Aktuelle Diagnostik und Therapie